Drug Hypersensitivity clinical trials
The registry lists 57 studies for Drug Hypersensitivity across more than 10 countries. 18 are recruiting or about to start. 47 of them are mainly about Drug Hypersensitivity (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-22. Counting its 2 narrower conditions too, such as Hand-Foot Syndrome: 138 studies, 34 open.
Get an email when these change. Save the Drug Hypersensitivity studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
University Hospital, Montpellier (8) · Chulalongkorn University (4) · University Hospital, Lille (2) · Bausch & Lomb Incorporated (2) · Seoul National University Hospital (2) · The University of Hong Kong (2) · University of Tennessee (1) · Dana-Farber Cancer Institute (1)
What is being tested here
Drugs under test in Drug Hypersensitivity studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 5
- Dec 2026Teicoplanin Allergy Testing Using Autologous Serum (TATAS) · University Hospital Southampton NHS Foundation Trust
- May 2027Proactive Immune Tolerance Induction in Chemotherapy for Gynecologic Cancer · Seoul National University Hospital
- Jul 2027In Search of the Correct Diagnosis of Beta-lactam Allergy: From the Validation of a Risk Stratification Tool to Accurate Endotyping · Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud
- Aug 2027Provocation After Nurse-Directed Assessment (PANDA) Study · The University of Hong Kong
- Oct 2027Origin and Function of Eosinophilic Polynuclear During DRESS Syndrome · University Hospital, Lille
Who these studies take
Of the 12 Drug Hypersensitivity studies recruiting now, 8 (67%) set no upper age limit and 3 (25%) stop at 75 or younger. 2 (17%) take children under 18. 1 (8%) are for women only and 0 (0%) for men only; 6 (50%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 2 (17%) | 2 (17%) |
| 18 | 10 (83%) | 10 (83%) |
| 30 | 11 (92%) | 10 (83%) |
| 40 | 10 (83%) | 9 (75%) |
| 50 | 10 (83%) | 9 (75%) |
| 65 | 10 (83%) | 9 (75%) |
| 75 | 9 (75%) | 8 (67%) |
| 85 | 9 (75%) | 8 (67%) |
Across all 57 studies, recruiting or not: 18% stop at 75 or younger and 16% at 65; 40% take children; 4% are for women only and 0% for men only; 28% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
What changed recently
From the registry's own updates since Oct 13, 2026.
Started recruiting1
- Post-market Safety Study of LUMISIGHTOct 14, 2026NCT07572162
Studies
Recruiting first, then most recently updated. Showing 50 of 57. Browse all 57 → or search them.
- Post-market Safety Study of LUMISIGHTRecruitingNCT075721621 country
- Proactive Immune Tolerance Induction in Chemotherapy for Gynecologic CancerRecruitingNCT06977594Not applicable1 country
- Optimizing the Diagnostic Approach to Cephalosporin Allergy TestingRecruitingNCT06406114Phase 21 country
- Interest of a Targeted Therapy for the Treatment of a Severe Form of Hypersensitivity to Drug (DRESS Syndrome)Not yet recruitingNCT06734884Phase 21 country
- Provocation After Nurse-Directed Assessment (PANDA) StudyRecruitingNCT071278351 country
- Origin and Function of Eosinophilic Polynuclear During DRESS SyndromeRecruitingNCT043301181 country
- Establishment of a Registry for Immediate Drug AllergyNot yet recruitingNCT07390370
- Analysis of the Role of IgE Proteoforms in Health and DiseaseRecruitingNCT073281781 country
- Support Tool for Antibiotic Allergy deLabelingRecruitingNCT06771440Not applicable1 country
- In Search of the Correct Diagnosis of Beta-lactam Allergy: From the Validation of a Risk Stratification Tool to Accurate EndotypingNot yet recruitingNCT07011212Not applicable
- Penicillin Allergy Delabeling After a One-Dose Versus Two-Dose Graded Direct Oral ChallengeRecruitingNCT06303128Phase 31 country
- Teicoplanin Allergy Testing Using Autologous Serum (TATAS)RecruitingNCT06803758Not applicable1 country
- High Dimensional Analysis of Immune Cells in Pediatric PatientsRecruitingNCT058208021 country
- Inpatient Penicillin Delabeling for Low-Risk PatientsEnrolling by invitationNCT06414694Phase 41 country
- A Training Program of Drug Allergy for Healthcare ProfessionalsNot yet recruitingNCT06399601Not applicable1 country
- Over-the-Counter Antihistamines & Heat StressRecruitingNCT06217367Phase 41 country
- Allergy Diagnostic Test Based on Microchip TechnologyNot yet recruitingNCT06167564Not applicable1 country
- GERAP's Epidemiological Survey on Perioperative Hypersensitivity ReactionsRecruitingNCT046549231 country
- Drug Provocation Test (DPT) to ParacetamolCompletedNCT037711181 country
- De-labeling of Patients With False Diagnosis of Penicillin AllergyCompletedNCT03581604Not applicable1 country
- A Penicillin Allergy Delabeling Inhospital Model Hospitalized PatientsTerminatedNCT07194824Not applicable1 country
- Turkish Version of the Parent-Reported Drug Hypersensitivity Quality of Life QuestionnaireCompletedNCT070694391 country
- Optimal Doses for Drug Provocation Tests to Beta-lactamsCompletedNCT02839551Not applicable1 country
- Standardised Drug Provocation Testing in Perioperative HypersensitivityCompletedNCT06065137Not applicable1 country
- Management of Drug Hypersensitivity in ChildrenTerminatedNCT020311201 country
- Defining ENDOtypes in Perioperative Hypersensitivity by Extensive Cellular and Molecular PHENotyping (ENDOPHEN)CompletedNCT040061061 country
- Preoperative Survey to Evaluate Patient AllergyCompletedNCT056707561 country
- An Evaluation of Healthcare Providers' Adherence to Pharmacovigilance Practices in an African CommunityCompletedNCT064281621 country
- Validation of the English Version of the Drug Hypersensitivity Quality of Life QuestionnaireCompletedNCT065231921 country
- Vitamin D Levels in Non-immediate Drug Hypersensitivity Case-control StudyCompletedNCT062631401 country
- Safety and Efficacy of an Oral Penicillin Challenge in Low Risk Hospitalized PatientsStatus unknownNCT04408508Not applicable
- Perioperative Hypersensitivity in ChildrenCompletedNCT05706246Not applicable1 country
- A Study to Assess the Hypersensitivity to TAK-880 Compared to Gammagard S/D in Blood of Children, Teenagers and AdultsCompletedNCT052690821 country
- Drug Allergy Labels After Drug Allergy InvestigationCompletedNCT048276021 country
- Medical Device for Drug Allergy DiagnosisCompletedNCT02839811Not applicable1 country
- Drug Challenges Without Prior Skin TestingCompletedNCT03158831Phase 11 country
- Retrospective Study of Immediate Hypersensitivity (IHS) Reactions to Platinum Salts in the University Hospital of NancyStatus unknownNCT049207211 country
- Prediction of Rituximab Hypersensitivity and Desensitization TreatmentStatus unknownNCT04610242Not applicable1 country
- Cephalosporin HypersensitivityCompletedNCT044216381 country
- Drug Provocation Test (DPT) to Non Steroidal Anti-inflammatory Drugs (NSAID)CompletedNCT037432201 country
- Multiple Drug Hypersensitivity SyndromeCompletedNCT037844821 country
- The Diagnosis of Beta-lactam Hypersensitivity in ThailandCompletedNCT016670551 country
- Severe Cutaneous Adverse Reactions in ThailandStatus unknownNCT025749881 country
- Allergic Versus Non Allergic Hypersensitivity Drug Reaction (BdDAllergo)TerminatedNCT033695091 country
- Improved Basophil Activation Test (BAT) in the Diagnostics of Drug AllergyStatus unknownNCT031640441 country
- Study of Omalizumab as Adjuvant Therapy in Chemotherapy DesensitizationCompletedNCT02118987Phase 11 country
- Allergy Testing of Patients Labeled as Penicillin AllergicCompletedNCT029836301 country
- Evaluation of TNF-α Blockade Effect in Patients With Severe Cutaneous Adverse Drug ReactionsCompletedNCT01276314Not applicable1 country
- The Clinical Study on Pseudo-allergic Reaction to Anesthetic Drugs During General AnesthesiaStatus unknownNCT031571801 country
- Predictive Models for Betalactam AllergyCompletedNCT03076749